Question 1

What is UCB Pharma (United Kingdom) known for?

Accepted Answer

In research, UCB Pharma (United Kingdom) stands highest in Life Sciences (#1,320 of 11,023 worldwide), Health Sciences (#2,028 of 16,688 worldwide) and Medicine (#2,010 of 14,558 worldwide), over all time.

Question 2

How does UCB Pharma (United Kingdom) rank in research?

Accepted Answer

UCB Pharma (United Kingdom) ranks #12,244 of 22,385 institutions worldwide on research quality in 2022-now (#3,505 all time), and #404 of 862 in the United Kingdom.

Question 3

Who are the top researchers at UCB Pharma (United Kingdom)?

Accepted Answer

Ranked on the quality score, Andrew Docherty, Sue Stephens and J.S. Emtage lead among researchers whose main affiliation is UCB Pharma (United Kingdom).

Question 4

What are the most cited papers from UCB Pharma (United Kingdom)?

Accepted Answer

The most cited paper from UCB Pharma (United Kingdom) is "Natural products in drug discovery: advances and opportunities" (Atanas G. Atanasov et al., 2021), with 5,395 citations. Next come "Rings in Drugs" (2,540) and "Organic synthesis provides opportunities to transform drug discovery" (1,554).

Question 5

Which research topics does UCB Pharma (United Kingdom) publish most on?

Accepted Answer

By volume in 2022-now: Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments, Myasthenia Gravis and Thymoma and Rheumatoid Arthritis Research and Therapies.

Question 6

Which keywords describe research at UCB Pharma (United Kingdom)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Autoantibodies, TGF-ß, Regulatory T Cells, Immune System, Inflammation, IL-17, TH17 Cells and Monoclonal Antibodies.

Question 7

Which fields of science does UCB Pharma (United Kingdom) work in?

Accepted Answer

In 2022-now, 51% of research at UCB Pharma (United Kingdom) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (49%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (12%). It does 2.1× the world's share of Health Sciences.

Question 8

Is UCB Pharma (United Kingdom)'s research output growing?

Accepted Answer

Output in 2022-2025 was 2% lower than in 2018-2021.